Neurological Disorder Drugs Market 2022: Key Strategies, Historical Analysis, Trends, New Opportunities and Forecast Till 2028
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
This report elaborates the market size, market characteristics, and market growth of the Neurological Disorder Drugs industry, and breaks down according to the type, application, and consumption area of Neurological Disorder Drugs. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Neurological Disorder Drugs in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.
Key players in the global Neurological Disorder Drugs market covered in Chapter 13:
AstraZeneca
Boehringer Ingelheim GmbH
Bayer AG
Merck & Co.
GlaxoSmithKline plc
F. Hoffmann-La Roche Ltd.
Novartis AG
Teva Pharmaceutical Industries Ltd.
In Chapter 6, on the basis of types, the Neurological Disorder Drugs market from 2015 to 2025 is primarily split into:
Antipsychotic
Hypnotic & Sedative
Analgesics
Anticoagulants
Others
In Chapter 7, on the basis of applications, the Neurological Disorder Drugs market from 2015 to 2025 covers:
Hospital
Clinic
Home
Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Neurological Disorder Drugs Market - Research Scope
1.1 Study Goals
1.2 Market Definition and Scope
1.3 Key Market Segments
1.4 Study and Forecasting Years
2 Neurological Disorder Drugs Market - Research Methodology
2.1 Methodology
2.2 Research Data Source
2.2.1 Secondary Data
2.2.2 Primary Data
2.2.3 Market Size Estimation
2.2.4 Legal Disclaimer
3 Neurological Disorder Drugs Market Forces
3.1 Global Neurological Disorder Drugs Market Size
3.2 Top Impacting Factors (PESTEL Analysis)
3.2.1 Political Factors
3.2.2 Economic Factors
3.2.3 Social Factors
3.2.4 Technological Factors
3.2.5 Environmental Factors
3.2.6 Legal Factors
3.3 Industry Trend Analysis
3.4 Industry Trends Under COVID-19
3.4.1 Risk Assessment on COVID-19
3.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
3.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
3.5 Industry Risk Assessment
4 Neurological Disorder Drugs Market - By Geography
4.1 Global Neurological Disorder Drugs Market Value and Market Share by Regions
4.1.1 Global Neurological Disorder Drugs Value ($) by Region (2015-2020)
4.1.2 Global Neurological Disorder Drugs Value Market Share by Regions (2015-2020)
4.2 Global Neurological Disorder Drugs Market Production and Market Share by Major Countries
4.2.1 Global Neurological Disorder Drugs Production by Major Countries (2015-2020)
4.2.2 Global Neurological Disorder Drugs Production Market Share by Major Countries (2015-2020)
4.3 Global Neurological Disorder Drugs Market Consumption and Market Share by Regions
4.3.1 Global Neurological Disorder Drugs Consumption by Regions (2015-2020)
4.3.2 Global Neurological Disorder Drugs Consumption Market Share by Regions (2015-2020)
5 Neurological Disorder Drugs Market - By Trade Statistics
5.1 Global Neurological Disorder Drugs Export and Import
5.2 United States Neurological Disorder Drugs Export and Import (2015-2020)
5.3 Europe Neurological Disorder Drugs Export and Import (2015-2020)
5.4 China Neurological Disorder Drugs Export and Import (2015-2020)
5.5 Japan Neurological Disorder Drugs Export and Import (2015-2020)
5.6 India Neurological Disorder Drugs Export and Import (2015-2020)
5.7
6 Neurological Disorder Drugs Market - By Type
6.1 Global Neurological Disorder Drugs Production and Market Share by Types (2015-2020)
6.1.1 Global Neurological Disorder Drugs Production by Types (2015-2020)
6.1.2 Global Neurological Disorder Drugs Production Market Share by Types (2015-2020)
6.2 Global Neurological Disorder Drugs Value and Market Share by Types (2015-2020)
6.2.1 Global Neurological Disorder Drugs Value by Types (2015-2020)
6.2.2 Global Neurological Disorder Drugs Value Market Share by Types (2015-2020)
6.3 Global Neurological Disorder Drugs Production, Price and Growth Rate of Antipsychotic (2015-2020)
6.4 Global Neurological Disorder Drugs Production, Price and Growth Rate of Hypnotic & Sedative (2015-2020)
6.5 Global Neurological Disorder Drugs Production, Price and Growth Rate of Analgesics (2015-2020)
6.6 Global Neurological Disorder Drugs Production, Price and Growth Rate of Anticoagulants (2015-2020)
6.7 Global Neurological Disorder Drugs Production, Price and Growth Rate of Others (2015-2020)
7 Neurological Disorder Drugs Market - By Application
7.1 Global Neurological Disorder Drugs Consumption and Market Share by Applications (2015-2020)
7.1.1 Global Neurological Disorder Drugs Consumption by Applications (2015-2020)
7.1.2 Global Neurological Disorder Drugs Consumption Market Share by Applications (2015-2020)
7.2 Global Neurological Disorder Drugs Consumption and Growth Rate of Hospital (2015-2020)
7.3 Global Neurological Disorder Drugs Consumption and Growth Rate of Clinic (2015-2020)
7.4 Global Neurological Disorder Drugs Consumption and Growth Rate of Home (2015-2020)
8 North America Neurological Disorder Drugs Market
8.1 North America Neurological Disorder Drugs Market Size
8.2 United States Neurological Disorder Drugs Market Size
8.3 Canada Neurological Disorder Drugs Market Size
8.4 Mexico Neurological Disorder Drugs Market Size
8.5 The Influence of COVID-19 on North America Market
9 Europe Neurological Disorder Drugs Market Analysis
9.1 Europe Neurological Disorder Drugs Market Size
9.2 Germany Neurological Disorder Drugs Market Size
9.3 United Kingdom Neurological Disorder Drugs Market Size
9.4 France Neurological Disorder Drugs Market Size
9.5 Italy Neurological Disorder Drugs Market Size
9.6 Spain Neurological Disorder Drugs Market Size
9.7 The Influence of COVID-19 on Europe Market
10 Asia-Pacific Neurological Disorder Drugs Market Analysis
10.1 Asia-Pacific Neurological Disorder Drugs Market Size
10.2 China Neurological Disorder Drugs Market Size
10.3 Japan Neurological Disorder Drugs Market Size
10.4 South Korea Neurological Disorder Drugs Market Size
10.5 Southeast Asia Neurological Disorder Drugs Market Size
10.6 India Neurological Disorder Drugs Market Size
10.7 The Influence of COVID-19 on Asia Pacific Market
11 Middle East and Africa Neurological Disorder Drugs Market Analysis
11.1 Middle East and Africa Neurological Disorder Drugs Market Size
11.2 Saudi Arabia Neurological Disorder Drugs Market Size
11.3 UAE Neurological Disorder Drugs Market Size
11.4 South Africa Neurological Disorder Drugs Market Size
11.5 The Influence of COVID-19 on Middle East and Africa Market
12 South America Neurological Disorder Drugs Market Analysis
12.1 South America Neurological Disorder Drugs Market Size
12.2 Brazil Neurological Disorder Drugs Market Size
12.3 The Influence of COVID-19 on South America Market
13 Company Profiles
13.1 AstraZeneca
13.1.1 AstraZeneca Basic Information
13.1.2 AstraZeneca Product Profiles, Application and Specification
13.1.3 AstraZeneca Neurological Disorder Drugs Market Performance (2015-2020)
13.2 Boehringer Ingelheim GmbH
13.2.1 Boehringer Ingelheim GmbH Basic Information
13.2.2 Boehringer Ingelheim GmbH Product Profiles, Application and Specification
13.2.3 Boehringer Ingelheim GmbH Neurological Disorder Drugs Market Performance (2015-2020)
13.3 Bayer AG
13.3.1 Bayer AG Basic Information
13.3.2 Bayer AG Product Profiles, Application and Specification
13.3.3 Bayer AG Neurological Disorder Drugs Market Performance (2015-2020)
13.4 Merck & Co.
13.4.1 Merck & Co. Basic Information
13.4.2 Merck & Co. Product Profiles, Application and Specification
13.4.3 Merck & Co. Neurological Disorder Drugs Market Performance (2015-2020)
13.5 GlaxoSmithKline plc
13.5.1 GlaxoSmithKline plc Basic Information
13.5.2 GlaxoSmithKline plc Product Profiles, Application and Specification
13.5.3 GlaxoSmithKline plc Neurological Disorder Drugs Market Performance (2015-2020)
13.6 F. Hoffmann-La Roche Ltd.
13.6.1 F. Hoffmann-La Roche Ltd. Basic Information
13.6.2 F. Hoffmann-La Roche Ltd. Product Profiles, Application and Specification
13.6.3 F. Hoffmann-La Roche Ltd. Neurological Disorder Drugs Market Performance (2015-2020)
13.7 Novartis AG
13.7.1 Novartis AG Basic Information
13.7.2 Novartis AG Product Profiles, Application and Specification
13.7.3 Novartis AG Neurological Disorder Drugs Market Performance (2015-2020)
13.8 Teva Pharmaceutical Industries Ltd.
13.8.1 Teva Pharmaceutical Industries Ltd. Basic Information
13.8.2 Teva Pharmaceutical Industries Ltd. Product Profiles, Application and Specification
13.8.3 Teva Pharmaceutical Industries Ltd. Neurological Disorder Drugs Market Performance (2015-2020)
14 Market Forecast - By Regions
14.1 North America Neurological Disorder Drugs Market Forecast (2020-2025)
14.2 Europe Neurological Disorder Drugs Market Forecast (2020-2025)
14.3 Asia-Pacific Neurological Disorder Drugs Market Forecast (2020-2025)
14.4 Middle East and Africa Neurological Disorder Drugs Market Forecast (2020-2025)
14.5 South America Neurological Disorder Drugs Market Forecast (2020-2025)
15 Market Forecast - By Type and Applications
15.1 Global Neurological Disorder Drugs Market Forecast by Types (2020-2025)
15.1.1 Global Neurological Disorder Drugs Market Forecast Production and Market Share by Types (2020-2025)
15.1.2 Global Neurological Disorder Drugs Market Forecast Value and Market Share by Types (2020-2025)
15.2 Global Neurological Disorder Drugs Market Forecast by Applications (2020-2025)
List of Tables and Figures
Figure Neurological Disorder Drugs Picture
Table Neurological Disorder Drugs Key Market Segments
Figure Study and Forecasting Years
Figure Global Neurological Disorder Drugs Market Size and Growth Rate 2015-2025
Figure Industry PESTEL Analysis
Figure Global COVID-19 Status
Figure Market Size Forecast Comparison of Pre COVID-19 and Post COVID-19
Figure Global Neurological Disorder Drugs Value ($) and Growth Rate (2015-2020)
Table Global Neurological Disorder Drugs Value ($) by Countries (2015-2020)
Table Global Neurological Disorder Drugs Value Market Share by Regions (2015-2020)
Figure Global Neurological Disorder Drugs Value Market Share by Regions in 2019
Figure Global Neurological Disorder Drugs Production and Growth Rate (2015-2020)
Table Global Neurological Disorder Drugs Production by Major Countries (2015-2020)
Table Global Neurological Disorder Drugs Production Market Share by Major Countries (2015-2020)
Figure Global Neurological Disorder Drugs Production Market Share by Regions in 2019
Figure Global Neurological Disorder Drugs Consumption and Growth Rate (2015-2020)
Table Global Neurological Disorder Drugs Consumption by Regions (2015-2020)
Table Global Neurological Disorder Drugs Consumption Market Share by Regions (2015-2020)
Figure Global Neurological Disorder Drugs Consumption Market Share by Regions in 2019
Table Global Neurological Disorder Drugs Export Top 3 Country 2019
Table Global Neurological Disorder Drugs Import Top 3 Country 2019
Table United States Neurological Disorder Drugs Export and Import (2015-2020)
Table Europe Neurological Disorder Drugs Export and Import (2015-2020)
Table China Neurological Disorder Drugs Export and Import (2015-2020)
Table Japan Neurological Disorder Drugs Export and Import (2015-2020)
Table India Neurological Disorder Drugs Export and Import (2015-2020)
Table Global Neurological Disorder Drugs Production by Types (2015-2020)
Table Global Neurological Disorder Drugs Production Market Share by Types (2015-2020)
Figure Global Neurological Disorder Drugs Production Share by Type (2015-2020)
Table Global Neurological Disorder Drugs Value by Types (2015-2020)
Table Global Neurological Disorder Drugs Value Market Share by Types (2015-2020)
Figure Global Neurological Disorder Drugs Value Share by Type (2015-2020)
Figure Global Antipsychotic Production and Growth Rate (2015-2020)
Figure Global Antipsychotic Price (2015-2020)
Figure Global Hypnotic & Sedative Production and Growth Rate (2015-2020)
Figure Global Hypnotic & Sedative Price (2015-2020)
Figure Global Analgesics Production and Growth Rate (2015-2020)
Figure Global Analgesics Price (2015-2020)
Figure Global Anticoagulants Production and Growth Rate (2015-2020)
Figure Global Anticoagulants Price (2015-2020)
Figure Global Others Production and Growth Rate (2015-2020)
Figure Global Others Price (2015-2020)
Table Global Neurological Disorder Drugs Consumption by Applications (2015-2020)
Table Global Neurological Disorder Drugs Consumption Market Share by Applications (2015-2020)
Figure Global Neurological Disorder Drugs Consumption Share by Application (2015-2020)
Figure Global Hospital Consumption and Growth Rate (2015-2020)
Figure Global Clinic Consumption and Growth Rate (2015-2020)
Figure Global Home Consumption and Growth Rate (2015-2020)
Figure North America Neurological Disorder Drugs Market Consumption and Growth Rate (2015-2020)
Table North America Neurological Disorder Drugs Consumption by Countries (2015-2020)
Table North America Neurological Disorder Drugs Consumption Market Share by Countries (2015-2020)
Figure North America Neurological Disorder Drugs Consumption Market Share by Countries (2015-2020)
Figure United States Neurological Disorder Drugs Market Consumption and Growth Rate (2015-2020)
Figure Canada Neurological Disorder Drugs Market Consumption and Growth Rate (2015-2020)
Figure Mexico Neurological Disorder Drugs Market Consumption and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure Europe Neurological Disorder Drugs Market Consumption and Growth Rate (2015-2020)
Table Europe Neurological Disorder Drugs Consumption by Countries (2015-2020)
Table Europe Neurological Disorder Drugs Consumption Market Share by Countries (2015-2020)
Figure Europe Neurological Disorder Drugs Consumption Market Share by Countries (2015-2020)
Figure Germany Neurological Disorder Drugs Market Consumption and Growth Rate (2015-2020)
Figure United Kingdom Neurological Disorder Drugs Market Consumption and Growth Rate (2015-2020)
Figure France Neurological Disorder Drugs Market Consumption and Growth Rate (2015-2020)
Figure Italy Neurological Disorder Drugs Market Consumption and Growth Rate (2015-2020)
Figure Spain Neurological Disorder Drugs Market Consumption and Growth Rate (2015-2020)
Figure Europe COVID-19 Status
Figure Asia-Pacific Neurological Disorder Drugs Market Consumption and Growth Rate (2015-2020)
Table Asia-Pacific Neurological Disorder Drugs Consumption by Countries (2015-2020)
Table Asia-Pacific Neurological Disorder Drugs Consumption Market Share by Countries (2015-2020)
Figure Asia-Pacific Neurological Disorder Drugs Consumption Market Share by Countries (2015-2020)
Figure China Neurological Disorder Drugs Market Consumption and Growth Rate (2015-2020)
Figure Japan Neurological Disorder Drugs Market Consumption and Growth Rate (2015-2020)
Figure South Korea Neurological Disorder Drugs Market Consumption and Growth Rate (2015-2020)
Figure Southeast Asia Neurological Disorder Drugs Market Consumption and Growth Rate (2015-2020)
Figure India Neurological Disorder Drugs Market Consumption and Growth Rate (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Middle East and Africa Neurological Disorder Drugs Market Consumption and Growth Rate (2015-2020)
Table Middle East and Africa Neurological Disorder Drugs Consumption by Countries (2015-2020)
Table Middle East and Africa Neurological Disorder Drugs Consumption Market Share by Countries (2015-2020)
Figure Middle East and Africa Neurological Disorder Drugs Consumption Market Share by Countries (2015-2020)
Figure Saudi Arabia Neurological Disorder Drugs Market Consumption and Growth Rate (2015-2020)
Figure UAE Neurological Disorder Drugs Market Consumption and Growth Rate (2015-2020)
Figure South Africa Neurological Disorder Drugs Market Consumption and Growth Rate (2015-2020)
Figure South America Neurological Disorder Drugs Market Consumption and Growth Rate (2015-2020)
Table South America Neurological Disorder Drugs Consumption by Countries (2015-2020)
Table South America Neurological Disorder Drugs Consumption Market Share by Countries (2015-2020)
Figure South America Neurological Disorder Drugs Consumption Market Share by Countries (2015-2020)
Figure Brazil Neurological Disorder Drugs Market Consumption and Growth Rate (2015-2020)
Table AstraZeneca Company Profile
Table AstraZeneca Production, Value, Price, Gross Margin 2015-2020
Figure AstraZeneca Production and Growth Rate
Figure AstraZeneca Value ($) Market Share 2015-2020
Table Boehringer Ingelheim GmbH Company Profile
Table Boehringer Ingelheim GmbH Production, Value, Price, Gross Margin 2015-2020
Figure Boehringer Ingelheim GmbH Production and Growth Rate
Figure Boehringer Ingelheim GmbH Value ($) Market Share 2015-2020
Table Bayer AG Company Profile
Table Bayer AG Production, Value, Price, Gross Margin 2015-2020
Figure Bayer AG Production and Growth Rate
Figure Bayer AG Value ($) Market Share 2015-2020
Table Merck & Co. Company Profile
Table Merck & Co. Production, Value, Price, Gross Margin 2015-2020
Figure Merck & Co. Production and Growth Rate
Figure Merck & Co. Value ($) Market Share 2015-2020
Table GlaxoSmithKline plc Company Profile
Table GlaxoSmithKline plc Production, Value, Price, Gross Margin 2015-2020
Figure GlaxoSmithKline plc Production and Growth Rate
Figure GlaxoSmithKline plc Value ($) Market Share 2015-2020
Table F. Hoffmann-La Roche Ltd. Company Profile
Table F. Hoffmann-La Roche Ltd. Production, Value, Price, Gross Margin 2015-2020
Figure F. Hoffmann-La Roche Ltd. Production and Growth Rate
Figure F. Hoffmann-La Roche Ltd. Value ($) Market Share 2015-2020
Table Novartis AG Company Profile
Table Novartis AG Production, Value, Price, Gross Margin 2015-2020
Figure Novartis AG Production and Growth Rate
Figure Novartis AG Value ($) Market Share 2015-2020
Table Teva Pharmaceutical Industries Ltd. Company Profile
Table Teva Pharmaceutical Industries Ltd. Production, Value, Price, Gross Margin 2015-2020
Figure Teva Pharmaceutical Industries Ltd. Production and Growth Rate
Figure Teva Pharmaceutical Industries Ltd. Value ($) Market Share 2015-2020
Figure North America Market Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Consumption and Growth Rate Forecast (2020-2025)
Figure Asia-Pacific Market Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Consumption and Growth Rate Forecast (2020-2025)
Table Global Neurological Disorder Drugs Market Forecast Production by Types (2020-2025)
Table Global Neurological Disorder Drugs Market Forecast Production Share by Types (2020-2025)
Table Global Neurological Disorder Drugs Market Forecast Value ($) by Types (2020-2025)
Table Global Neurological Disorder Drugs Market Forecast Value Share by Types (2020-2025)
Table Global Neurological Disorder Drugs Market Forecast Consumption by Applications (2020-2025)
Table Global Neurological Disorder Drugs Market Forecast Consumption Share by Applications (2020-2025)
Research Methodology:
Neurological Disorder Drugs Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|